Rabbit Anti-EIF4A1 Recombinant Antibody (
7C3) (V2LY-0725-LY1025)

Schmidt, T., Dabrowska, A., Waldron, J. A., Hodge, K., Koulouras, G., Gabrielsen, M., ... & Bushell, M. (2022). Purine-rich RNA sequences in the 5′ UTR site-specifically regulate eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation. bioRxiv.

Li, F., Cao, K., Wang, M., Liu, Y., & Zhang, Y. (2022). Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/eukaryotic translation initiation factor 4A1 (EIF4A1) pathway. Bioengineered, 13(4), 10112-10123.

Wang, C., Leavenworth, J., Zhang, C., Liu, Z., Yuan, K. Y., Wang, Y., ... & Liu, R. (2022). Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer. Oncogene, 41(19), 2778-2785.

Ercan, H., Schrottmaier, W. C., Pirabe, A., Schmuckenschlager, A., Pereyra, D., Santol, J., ... & Zellner, M. (2021). Platelet phenotype analysis of COVID-19 patients reveals progressive changes in the activation of integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5. Frontiers in cardiovascular medicine, 8.

Zhao, Y., Wang, Y., Chen, W., Bai, S., Peng, W., Zheng, M., ... & Luan, Z. (2021). Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Cancer Cell International, 21(1), 1-13.

Wang, J., Pu, J., Zhang, Y., Yao, T., Luo, Z., Li, W., ... & Deng, Y. (2020). Exosome-transmitted long non-coding RNA SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma. Aging (Albany NY), 12(12), 11550.

Howard, C. M., Estrada, M., Terrero, D., Tiwari, A. K., & Raman, D. (2020). Identification of cardiac glycosides as novel inhibitors of eIF4A1-mediated translation in triple-negative breast cancer cells. Cancers, 12(8), 2169.

Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019). Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E. Journal of Experimental & Clinical Cancer Research, 38(1), 1-15.

Peters, T. L., Tillotson, J., Yeomans, A. M., Wilmore, S., Lemm, E., Jiménez-Romero, C., ... & Schatz, J. H. (2018). Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor ActivityNovel Screen for Translation Inhibitors Targeting eIF4A1. Clinical Cancer Research, 24(17), 4256-4270.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols